Interspecies differences in cancer susceptibility and toxicity

Drug Metabolism Reviews

Volumn 31, Issue 4, 1999, Pages 917-970

  Hengstler, Jan Georg ^c   Van Der Burg, Bart ^a   Steinberg, Pablo ^b   Oesch, Franz ^d  

^a HUBRECHT INSTITUTE   (Netherlands)

^b UNIVERSITY OF POTSDAM   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AFLATOXIN B1; DIGITOXIN; HETEROCYCLIC AMINE; POLYCYCLIC AROMATIC HYDROCARBON; TAMOXIFEN;

ACETYLATOR PHENOTYPE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENICITY; DNA ADDUCT; DNA METABOLISM; DRUG METABOLISM; HUMAN; NONHUMAN; TOXICITY;

AFLATOXIN B1; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BENZO(A)PYRENE; CARDIOTONIC AGENTS; CRICETINAE; DIGITOXIN; DISEASE SUSCEPTIBILITY; ENDOCRINE SYSTEM; ESTROGENS; FEMALE; HETEROCYCLIC COMPOUNDS; HUMANS; MALE; MICE; MICROSOMES, LIVER; NEOPLASMS; RABBITS; RATS; SPECIES SPECIFICITY; TAMOXIFEN; TETRACHLORODIBENZODIOXIN;

EID: 0032747614     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-100101946     Document Type: Article

References (170)

1. F. Oesch and B. Diener, Cell systems for use in studies on the relationship between foreign compound metabolism and toxicity, Pharmacol. Toxicol., 76, 325-327 (1995).
2. P. Steinberg, K. Biefang, S. Kiulies, T. Fischer, K. L. Platt, F. Oesch, T. Böttger, and J. G. Hengstler, Drug metabolizing capacity of cryopreserved human, rat and mouse liver parenchymal cells held in suspension, unpublished.
3. B. Diener, M. Traiser, M. Arand, J. Leissner, U. Witzsch, R. Hohenfellner, F. Fändrich, I. Vogel, D. Utesch, and F. Oesch, Xenobiotic metabolizing enzyme activities in isolated and cryopreserved human liver parenchymal cells, Toxic. In vitro, 8, 1161-1166 (1994).
4. J. Caldwell, Problems and opportunities in toxicity testing arising from species differences in xenobiotic metabolism, Toxicol. Lett., 64/65, 651-659 (1992).
5. R. H. Adamson, U. P. Thorgeirsson, and T. Sugimura, Extrapolation of heterocyclic amine carcinogenesis data from rodents and nonhuman primates to humans, Arch. Toxicol., 18(Suppl), 303-318 (1996).
6. M. Buonarati and J. S. Felton, Activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) to mutagenic metabolites, Carcinogenesis, 11, 1133-1138 (1990).
7. rd Princess Takamatsu Cancer Research Symposium, Princeton Science Publishers, Princeton, NJ, 1995.
8. E. G. Snyderwine, R. J. Turesky, K. W. Turteltaub, C. D. Davis, N. Sadrieh, H. A. Schut, M. Nago, T. Sugimura, U. P. Thorgeirsson, R. H. Adamson, and S. S. Thorgeirsson, Metabolism of food-derived heterocyclic amines in nonhuman primates, Mutat. Res., 376, 203-210 (1997).
9. C. D. Davis, R. H. Adamson, and E. G. Snyderwine, Studies on the mutagenic activation of heterocyclic amines by cynomolgus monkey, rat and human microsomes show that cynomolgus monkeys have a low capacity to N-oxidize the quinoxaline-type heterocyclic amines, Cancer Lett., 73, 95-104 (1993).
10. D. Sesardic, K. J. Cole, R. J. Edwards, D. S. Davies, P. E. Thomas, W. Levin, and A. R. Boobis, The inducibility and catalytic activity of cytochromes P450c (P4501A1) and P450d (P4501A2) in rat tissues, Biochem. Pharmacol., 39, 499-506 (1990).
11. D. Sesardic, A. R. Boobis, R. J. Edwards, and D. S. Davies, A form of cytochrome P450 in man, orthologous to form d in the rat catalyzes the O-deethylation of phenacetin and is inducible by cigarette smoking, Br. J. Clin. Pharmacol., 26, 363-372 (1989).
12. N. Sadrieh and E. G. Snyderwine, Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo|4,5-f]quinoxaline (MeIQx), Carcinogenesis, 16, 1549-1455 (1995).
13. R. J. Edwards, B. P. Murray, S. Murray, T. Schultz, D. Neubert, T. W. Gant, S. S. Thorgeirsson, A. R. Boobis, and D. S. Davies, Contribution of CYP 1A1 and CYP 1A2 to the activation of heterocyclic amines in monkeys and human, Carcinogenesis, 15, 829-836 (1994).
14. A. R. Boobis, N. J. Gooderham, R. J. Edwards, S. Murray, A. M. Lynch, M. Yadollahi-Farsani, and D. S. Davies, Enzymic and interindividual differences in the human metabolism of heterocyclic amines, Arch. Toxicol., 18(Suppl.), 286-302 (1996).
15. R. J. Turesky, H. U. Aeschbacher, H. P. Würzner, P. L. Skipper, and S. R. Tannenbaum, Major routes of metabolism of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in the rat, Carcinogenesis, 9, 1043-1048 (1988).
16. J. Alexander, H. Wallin, J. A. Home, and G. Becher, 4-(2-Amino-1-methylimidazo[4,5-b]pyrid-6-yl)phenyl sulfate - a major metabolite of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat, Carcinogenesis, 10, 1543-1547 (1989).
17. Y. Yamazoe, M. Abu-Zeid, S. Manabe, S. Toyama, and R. Kato, Metabolic activation of a protein pyrolysate promutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by rat liver microsomes and purified cytochrome P450, Carcinogenesis, 9, 105-109 (1988).
18. S. Ohmori, T. Horie, F. P. Guengerich, M. Kiuchi, and M. Kitada, Purification and characterization of two forms of hepatic microsomal cytochrome P450 from untreated cynomolgus monkeys, Arch. Biochem. Biophys., 305, 405-413 (1993).
19. T. Aoyama, H. V. Gelboin, and F. J. Gonzalez, Mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline by complementary DNA-expressed human liver P-450, Cancer Res., 50, 2060-2063 (1990).
20. D.-X. Lin, N. P. Lang, and F. F. Kadlubar, Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice, Drug Metab. Disp., 23, 518-524 (1995).
21. H. Wallin, A. Milkalsen, F. P. Guengerich, M. Ingelman-Sundberg, K. E. Solberg, O. J. Rossland, and J. Alexander, Differential rates of metabolic activation and detoxication of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by different cytochrome P450 enzymes, Carcinogenesis, 11, 489-492 (1990).
22. J. G. Hengstler, M. Arand, M. E. Herrero, and F. Oesch, Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: Influence on cancer susceptibility, in Genes and Environment in Cancer (H. M. Rabes, ed.), Karger, Bonn, 1998.
23. I. C. Roberts-Thomson, P. Ryan, K. K. Khoo, W. J. Hart, A. J. McMichael, and R. N. Butler, Diet, acetylator phenotype, and risk of colorectal neoplasia, Lancet, 347, 1372-1374 (1996).
24. M. H. Schiffmann and J. S. Felton, Fried foods and the risk of colon cancer, Am. J. Epidemiol., 131, 376-378 (1990).
25. M. Gerhardsson de Verdier, U. Hagman, R. K. Peters, G. Steineck, and E. Overvik, Meat cooking methods and colorectal cancer: A case-referent study in Stockholm, Int. J. Cancer, 49, 520-525 (1991).
26. N. P. Lang, M. A. Butler, J. Massengill, M. Lawson, R. C. Stotts, M. Hauer-Jensen, and F. F. Kadlubar, Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps, Cancer Epidemiol. Biomarkers Prev., 3, 675-682 (1994).
27. E. Giovannucci, E. B. Rimm, M. J. Stampfer, G. A. Colditz, A. Ascherio, and W. C. Willett, Intake of fat, meat and fiber in relation to risk of colon cancer in men, Cancer Res., 54, 2390-2397 (1994).
28. F. Oesch, J. G. Hengstler, and J. Fuchs, Cigarette smoking protects mononuclear blood cells of carcinogen exposed workers from additional work-exposure induced DNA single strand breaks, Mutat. Res., 321, 175-185 (1994).
29. F. Morel, O. Fardel, D. J. Meyer, S. Langouet, K. S. Gilmore, B. Meunier, C. P. Tu, T. W. Kensler, B. Ketterer, and A. Guillouzo, Preferential increase of glutathione S-transferase class alpha transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene, and dithiolethiones, Cancer Res., 53, 231-234 (1993).
30. D. Schrenk, T. Stuven, G. Goh, R. Viebahn, and K. W. Bock, Induction of CYP1A and glutathione S-transferase activities by 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatocyte cultures, Carcinogenesis, 16, 943-946 (1995).
31. R. Sinha, N. Rothman, E. D. Brown, S. D. Mark, R. N. Hoover, N. E. Caporaso, O. A. Levander, M. G. Knize, N. P. Lang, and F. F. Kadlubar, Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytochrome P450 1A2 activity in humans, Cancer Res., 54, 6154-6159 (1994).
32. 1, in Control Mechanisms of Carcinogenesis (J. G. Hengstler and F. Oesch, eds.), Druckerei Thieme, Mainz, 1996.
33. C. P. Wild, A. M. Jansen, L. Cova, and R. Montesano, Molecular dosimetry of aflatoxin exposure: Contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus, Environ. Health Perspect., 99, 115-122 (1993).
34. W. F. Busby and G. N. Wogan, Aflatoxins, in Chemical Carcinogens, Volume 2 (C. E. Searle, ed.), American Chemical Society Monograph 182, American Chemical Society, Washington, DC., 1984, pp. 945-1136.
35. I. Ueno, L. Friedman, and C. L. Stone, Species difference in the binding of aflatoxin B1 to hepatic macromolecules, Toxicol. Appl. Pharmacol., 52, 177-180 (1980).
36. 1 to cellular macromolecules in the rat and hamster, Chem. Biol. Interact., 11, 123-131 (1975).
37. 1 binding to exogenous and endogenous DNA by cytosolic glutathione S-transferase in rat liver, Carcinogenesis, 5, 269-276 (1984).
38. 1 to liver DNA of rat, mouse and pig, Chem. Biol. Interact., 32, 249-250 (1980).
39. R. G. Croy and G. N. Wogan, Quantitative comparison of covalent aflatoxin-DNA adducts formed in rat and mouse livers and kidneys, J. Natl. Cancer Inst., 66, 761-768 (1981).
40. 1 and 2-acetylaminofluorene to rat, mouse and human hepatocyte DNA: The relationship of DNA binding to carcinogenicity, Carcinogenesis, 9, 711-716 (1988).
41. W. A. Anwar, M. M. Khalil, and C. P. Wild, Micronuclei, chromosomal aberrations and aflatoxin-albumin adducts in experimental animals after exposure to aflatoxin B1, Mutat. Res., 322, 61-67 (1994).
42. K. L. Steinmetz, C. E. Green, J. P. Bakke, D. K. Spak, and J. C. Mirsalis, Induction of unscheduled DNA synthesis in primary cultures of rat, mouse, hamster, and human hepatocytes, Mutat. Res., 206, 91-102 (1988).
43. F. P. Guengerich, Metabolic control of carcinogens, in Control Mechanisms of Carcinogens (J. G. Hengstler and F. Oesch, eds.), Druckerei Thieme, Mainz, 1996.
44. 1 carcinogenesis: Comparative kinetics of microsomal biotransformation, Cancer Res., 50, 615-620 (1990).
45. 1 by human, mouse and rat liver preparations: Effect on SCE in human mononuclear leucocytes, Mutat. Res., 373, 257-264 (1997).
46. 1, Cancer Res., 54, 101-108 (1994).
47. 1 biotransformation in rat liver: Implications for human chemointervention, Cancer Res., 56, 2306-2313 (1996).
48. 1-epoxide and other chemicals, Pharmacogenetics, 5, 224-233 (1995).
49. 1-8,9-epoxide conjugating activities of two bacterially expressed alpha class glutathione S-transferase isozymes from mouse and rat, Biochem. Biophys. Res. Commun., 188, 597-603 (1992).
50. 1 in the rat is associated with the expression of a novel alpha-class glutathione S-transferase subunit Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide, Biochem. J., 279, 385-398 (1991).
51. 1, Toxicol. Appl. Pharmacol., 105, 351-363 (1990).
52. D. L. Eaton and E. P. Gallagher, Mechanism of aflatoxin carcinogenesis, Annu. Rev. Pharmacol. Toxicol., 34, 135-172 (1994).
53. 1 by the rat, Cancer Res., 36, 4663-4671 (1976).
54. R. C. Shank, N. Bhamarapravati, J. E. Gordon, and G. N. Wogan, Dietary aflatoxins and human liver cancer. IV. Incidence of primary liver cancer in two municipal populations in Thailand, Food Cosmet. Toxicol., 10, 171-179 (1972).
55. F. G. Peers and C. A. Linsell, Dietary aflatoxins and human primary liver cancer, Ann. Nutr. Aliment, 31, 1005-1018 (1997).
56. B. B. Rasmussen and K. Brosen, Determination of urinary metabolites of caffeine for the assessment of cytochrome P450 1A2, xanthine oxidase, and N-acetyltransferase activity in humans, Ther. Drug Monit., 18, 254-262 (1996).
57. E. P. Horn, M. A. Tucker, G. Lambert, D. Silverman, D. Zametkin, R. Sinha, T. Hartge, M. T. Landi, and N. E. Caporaso, A study of gender-based cytochrome P4501A2 variability: A possible mechanism for the male excess of bladder cancer, Cancer Epidemiol. Biomarkers Prev., 4, 529-533 (1995).
58. M. G. Bolton, A. Munoz, L. P. Jacobson, J. D. Groopman, Y. Y. Maxuitenko, B. D. Roebuck, and T. W. Kensler. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis, Cancer Res., 53, 3499-3504 (1993).
59. S. Langouet, B. Coles, F. Morel, L. Becquemont, P. Beaune, F. P. Guengerich, B. Ketterer, and A. Guillouzo, Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture, Cancer Res., 55, 5574-5579 (1995).
60. F. Morel, S. Langouet, K. Maheo, and A. Guillouzo, The use of primary hepatocyte cultures for the evaluation of chemoprotective agents, Cell Biol. Toxicol., 13, 323-329 (1997).
61. A. Luch and K. L. Platt, Metabolism, DNA-interaction and mutagenesis: Fundamental events in carcinogenesis by polycyclic aromatic hydrocarbons, in Control Mechanisms of Carcinogenesis (J. G. Hengstler and F. Oesch, eds.), Druckerei Thieme, Mainz, 1996, pp. 66-97.
62. T. L. Dao, Carcinogenesis of mammary gland in rat, Progr. Exp. Tumor Res., 5, 157-216 (1964).
63. C. B. Huggins, Experimental Leukemia and Mammary Cancer, University of Chicago Press, Chicago, 1979, pp. 73-99.
64. C. J. Moore, S. R. Eldridge, W. A. Tricomi, and M. N. Gould, Quantitation of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene binding to nuclear macromolecules in human and rat mammary epithelial cells, Cancer Res., 47, 2609-2613 (1987).
65. C. J. Moore, D. Pruess-Schwartz, R. J. Mauthe, M. N. Gould, and W. M. Baird, Interspecies differences in the major DNA adducts formed from benzo[a]pyrene but not 7,12-dimethylbenz[a]anthracene in rat and human mammary cell cultures, Cancer Res., 47, 4402-4406 (1987).
66. M. N. Gould, D. R. Grau, L. A. Seidman, and C. J. Moore, Interspecies comparison of human and rat mammary epithelial cell-mediated mutagenesis by polycyclic aromatic hydrocarbons, Cancer Res., 46, 4942-4945 (1986).
67. J. DiGiovanni, J. R. Romson, D. Linville, and M. R. Juchau, Covalent binding of polycyclic aromatic hydrocarbons to adenine correlates with tumorigenesis in mouse skin. Cancer Lett. 7, 39-53 (1979).
68. D. H. Phillips, A. Hewer, and P. L. Grover, Aberrant activation of benzo-[a]pyrene in cultured rat mammary cells in vitro and following direct application in rat mammary glands in vivo, Cancer Res., 45, 4167-4174 (1985).
69. S. R. Eldridge, M. N. Gould, and B. E. Butterworth, Genotoxicity of environmental agents in human mammary epithelial cells, Cancer Res., 52, 5617-5621 (1992).
70. D. Li, M. Wang, K. Dhingra, and W. N. Hittelman, Aromatic DNA adducts in adjacent tissues of breast cancer patients: Clues to breast cancer etiology, Cancer Res., 56, 287-293 (1996).
71. F. Oesch, D. Raphael, H. Schwind, and H. R. Glatt, Species differences in activating and inactivating enzymes related to the control of mutagenic metabolites, Arch. Toxicol., 39, 97-108 (1977).
72. F. Oesch, Species differences in activating and inactivating enzymes related to in vitro mutagenicity mediated by tissue preparations from these species, Arch. Toxicol., 3(Suppl.), 179-194 (1980).
73. H. R. Glatt and F. Oesch, Species differences in enzymes controlling reactive epoxides, Arch. Toxicol., 10(Suppl.) 111-124, (1987).
74. C. E. Phillipson and C. Ioannides, Metabolic activation of polycyclic aromatic hydrocarbons to mutagens in the Ames test by various animal species including man, Mutat. Res., 211, 147-151 (1989).
75. 32P-postlabeling analysis of benzo[a]pyrene-DNA adducts in vitro upon activation of benzo[a]pyrene by human, rabbit and rodent liver microsomes, Carcinogenesis, 14, 1945-1950 (1993).
76. A. Seidel, V. J. Soballa, G. Raab, H. Frank, H. Greim, G. Grimmer, J. Jacob, and J. Doehmer, Regio-and stereoselectivity in the metabolism of benzo[c]phenanthrene mediated by genetically engineered V79 Chinese hamster cells expressing rat and human cytochromes P450, Environ. Toxicol. Pharmacol., 5, 179-196 (1998).
77. E. E. McConnell, J. A. Moore, J. K. Haseman, and M. W. Harris, The comparative toxicity of chlorinated dibenzo-p-dioxin in mice and guinea pigs, Toxicol. Appl. Pharmacol., 44, 335-356 (1978).
78. O. Hankinson, S. G. Bacsi, B. N. Fukunaga, K. R. Kozak, S. E. McNulty, E. Minehart, M. R. Probst, S. Reisz-Porszasz, W. Sun, and J. Zhang, Role of the aryl hydrocarbon receptor in carcinogenesis, in Control Mechanisms of Carcinogenesis (J. G. Hengstler and F. Oesch, eds.), Druckerei Thieme, Mainz, 1996.
79. P. Fernandez-Salguero, T. Pineau, D. M. Hilbert, T. McPhail, S. S. Lee, S. Kimura, D. W. Nebert, S. Rudikoff, J. M. Ward, and F. J. Gonzalez, Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor, Science, 268, 722-726 (1995).
80. F. Andreola, P. M. Fernandez-Salguero, M. V. Chiantore, M. P. Petkovich, F. J. Gonzalez, and L. M. DeLuca. Aryl hydrocarbon receptor knockout mice (AHR-/-) exhibit liver retinoid accumulation and reduced retinoic acid metabolism, Cancer Res., 57, 2835-2838 (1997).
81. P. M. Fernandez-Salguero, D. M. Hilbert, S. Rudikoff, J. M. Ward, and F. J. Gonzalez, Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity, Toxicol. Appl. Pharmacol., 140, 173-179 (1996).
82. K. R. Kozak, B. Abbott, and O. Hankinson, ARNT-deficient mice and placental differentiation, Dev. Biol., 191, 287-305 (1997).
83. B. Schweiz, J. Norris, G. Sparschu, V. Rowe, P. Gehring, J. Emerson, and C. Gerbig, Toxicology of chlorinated dibenzo-p-dioxins, Environ. Health Perspect., 5, 87-99 (1973).
84. J. R. Olson, M. A. Holscher, and R. A. Neal, Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the golden Syrian hamster, Toxicol. Appl. Pharmacol., 55, 67-78 (1980).
85. R. E. Peterson, H. M. Theobald, and G. L. Kimmel, Developmental and reproductive toxicity of dioxins and related compounds: Cross-species comparisons, Crit. Rev. Toxicol., 23, 283-335 (1993).
86. J. E. Huff, A. G. Salmon, N. K. Hooper, and L. Zeise, Long-term carcinogenesis studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin and hexachlorodibenzo-p-dioxins, Cell. Biol. Toxicol., 7(1), 67-74 (1991).
87. S. M. Hays, L. L. Aylward, N. J. Karch, and D. J. Paustenbach, The relative susceptibility of animals and humans to the carcinogenic hazard posed by exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: An analysis using standard and internal measures of dose, Chemosphere, 34, 1507-1522 (1997).
88. A. Poland, D. Palen, and E. Glover, Analysis of the four alleles of the murine aryl hydrocarbon receptor, Mol. Pharmacol., 46, 915-921 (1994).
89. J. E. Gielen, F. M. Goujon, and D. W. Nebert, Genetic regulation of aryl hydrocarbon hydroxylase induction. II. Simple Mendelian expression in mouse tissues in vivo, J. Biol. Chem., 247, 1125-1137 (1972).
90. A. Poland and E. Glover, 2,3,7,8-Tetrachlorodibenzo-p-dioxin: Segregation of toxicity with the Ah locus, Mol. Pharmacol., 17, 86 (1980).
91. K. G. Jones and G. D. Sweeney, Dependence of the porphyrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin upon inheritance of aryl hydrocarbon hydroxylase responsiveness, Toxicol. Appl. Pharmacol., 53, 42 (1980).
92. A. Vecchi, M. Sironi, M. Antonia, C. M. Recchia, and S. Garattini, Immunosuppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in strains of mice with different susceptibility, Proc. Natl. Acad. Sci. USA, 87, 6917 (1983).
93. R. Pohjanvirta, M. Viluksela, J. T. Tuomisto, M. Unkila, J. Karasinska, M. A. Franc, M. Holowenko, J. V. Giannone, P. A. Harper, J. Tuomisto, and A. B. Okey, Physicochemical differences in the AH receptors of the most TCDD-susceptible and the most TCDD-resistant rat strains, Toxicol. Appl. Pharmacol., 155, 82-95 (1999).
94. J. T. Tuomisto, M. Viluksela, R. Pohjanvirta, and J. Tuomisto, The AH receptor and a novel gene determine acute toxic responses to TCDD: Segregation of the resistant alleles to different rat lines, Toxicol. Appl. Pharmacol., 155, 71-81 (1999).
95. J. S. Nakai, M. J. Winhall, and N. J. Bunce, Comparative kinetic study of the binding between 2,3,7,8-tetrachlorodibenzo-p-dioxin and related ligands with the hepatic Ah receptors from several rodent species, J. Biochem. Toxicol., 9, 199-209 (1997).
96. P. A. Bank, E. F. Yao, C. L. Phelps, P. A. Harper, and M. S. Denison. Species-specific binding of transformed Ah receptor to a dioxin responsive transcriptional enhancer, Eur. J. Biochem, 228, 85-94 (1992).
97. K. Rozman, A critical review on the mechanisms of toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Implications for human safety assessment, Derm. Beruf. Umwelt, 37, 81-92 (1989).
98. L. D. W. Weber, M. Lebofsky, B. U. Stahl, J. R. Gorski, G. Muzi, and K. Rozman, Reduced activities of key enzymes of gluconeogenesis as a possible cause of acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats, Toxicology, 66, 133 (1991).
99. M. Unkila, M. Ruotsalainen, R. Pohjanvirta, M. Viluksela, E. MacDonald, J. Tuomistro, K. Rozman, and J. Tuomisto, Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on tryptophan and glucose homeostasis in most TCDD-susceptible and the most TCDD-resistent species, guinea pigs and hamsters, Arch. Toxicol., 69, 677-683 (1995).
100. M. Unkila, R. Pohjanvirta, E. MacDonald, and J. Tuomistro, Characterization of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced brain serotonin metabolism in the rat, Eur. J. Pharmacol., 270, 157-166 (1994).
101. H. J. Geyer, K.-W. Schramm, I. Scheunert, K. Schughart, J. Buters, W. Wurst, H. Greim, R. Kluge, C. E. W. Steinberg, A. Kettrup, B. Madhukar, J. R. Olson, and M. A. Gallo, Considerations on genetic and environmental factors that contribute to resistance or sensitivity of mammals including humans to toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds, Ecotoxicol, Environ. Safety, 36, 213-230 (1997).
102. G. S. Lawrence and F. A. Gobas, A pharmacokinetic analysis of interspecies extrapolation in dioxin risk assessment, Chemosphere, 35, 427-452 (1997).
103. V. J. Wroblewski and J. R. Olson, Hepatic metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the rat and guinea pig, Toxicol. Appl. Pharmacol., 81, 231-240 (1985).
104. R. J. Kavlock, G. P. Daston, C. DeRosa, P. Fenner-Crisp, L. E. Gray, S. Kaattar, G. Lucier, M. Luster, M. J. Mac, C. Maczka, R. Miller, J. Moore, R. Rolland, G. Scott, D. M. Sheehan, T. Sinks, and H. A. Tilson, Research needs for the risk assessment of health and environmental effects of endocrine disruptors: A report of the U.S. EPA-sponsored workshop, Environ. Health Perspect., 104(Suppl. 4), 715-740 (1996).
105. S. H. Safe, Environmental and dietary estrogens and human health: Is there a problem? Environ. Health Perspect., 103, 346-351 (1995).
106. L. J. Guillette, T. S. Gross, G. R. Masson, J. M. Matter, H. F. Percival, and A. R. Woodward, Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida, Environ. Health Perspect., 102, 680-688 (1994).
107. R. J. Kavlock and G. T. Ankley, A perspective on the risk assessment process for endocrine-disruptive effects on wildlife and human health, Risk Anal., 16, 731-739 (1996).
108. K. Fent, Ecotoxicology of organotin compounds, Crit. Rev. Toxicol. 26, 1-117 (1996).
109. J. J. Jardine, G. J. Van der Kraak, and K. R. Munkittrick, Capture and confinement stress in white sucker exposed to bleached kraft pulp mill effluent, Ecotoxicol. Environ. Safety, 33, 287-298 (1996).
110. D. L. MacLatchy and G. J. Van Der Kraak, The phytoestrogen beta-sitosterol alters the reproductive endocrine status of goldfish, Toxicol. Appl. Pharmacol., 134, 305-312 (1995).
111. M. Gilbertson, T. Kubiak, J. Ludwig, and G. Fox, Great Lakes embryo mortality, edema, and deformities syndrome in colonial fish-eating birds: Similarity to chic-edema disease, J. Toxicol. Environ. Health, 33, 455-520 (1991).
112. A. L. Herbst, H. Ulfelder, and D. C. Poskanzer, Adenocarcinoma of the vagina. Association of Maternal Diethylstilbestrol Therapy with Tumor Appearance in Young Women, New Engl. J. Med., 284, 878-881 (1971).
113. T. Colton, E. R. Greenberg, K. Noller, L. Resseguie, C. Van Bennekom, T. Heeren, and Y. Zhang, Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up, JAMA, 269, 2096-2100 (1993).
114. S. L. Schantz, Developmental neurotoxicity of PCBs in humans: What do we know and where do we go from here? Neurotoxicol. Teratol., 18, 217-227 (1996).
115. T. J. Lai, Y. L. Guo, M. L. Yu, H. C. Ko, and C. C. Hsu, Cognitive development in Yucheng children, Chemosphere, 29, 2405-2411 (1994).
116. D. C. Morse, A. Plug, W. Wesseling, K. J. Van den Berg, and A. Brouwer, Persistent alterations in regional brain glial fibrillary acidic protein and synaptophysin levels following pre-and postnatal polychlorinated biphenyl exposure, Toxicol. Appl. Pharmacol., 139, 252-261 (1996).
117. A. Brouwer, D. C. Morse, M. C. Lans, A. G. Schuur, A. J. Murk, E. Klasson-Wehler, A. Bergman, and T. J. Visser, Interactions of persistent environmental organohalogens with the thyroid hormone system: Mechanisms and possible consequences for animal and human health, Toxicol. Ind. Health, 14, 59-84 (1998).
118. A. G. Schuur, F. F. Legger, M. E. Van Meeteren, M. J. Moonen, I. Van Leeuwen-Bol, A. Bergman, T. J. Visser, and A. Brouwer, In vitro inhibition of thyroid hormone sulfation by hydroxylated metabolites of halogenated aromatic hydrocarbons, Chem. Res. Toxicol., 11, 1075-1081 (1998).
119. J. De Boer, P. G. Wester, H. J. Klamer, W. E. Lewis, and J. P. Boon, Do flame retardants threaten ocean life? Nature, 394, 28-29 (1998).
120. P. T. Harrison, P. Holmes, and C. D. Humfrey, Reproductive health in humans and wildlife: Are adverse trends associated with environmental chemical exposure? Sci. Total Environ., 205, 97-106 (1997).
121. German Research Council (DFG), Hormonal active substances in diet (G. Eisenbrand, ed.), Wiley-VCH, Weinheim, 1998, pp. 1-23.
122. A. Cassidy, S. Bingham, and K. Setchell, Biological effects of isoflavones in young women: Importance of the chemical composition of soyabean products, Br. J. Nutr., 74, 587-601 (1995).
123. A. Cassidy, S. Bingham, and K. D. Setchell, Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women, Am. J. Clin. Nutr., 60, 333-340 (1995).
124. W. R. Obermeyer, S. M. Musser, J. M. Betz, R. E. Casey, A. E. Pohland, and S. W. Page, Chemical studies of phytoestrogens and related compounds in dietary supplements: Flax and chaparral, Proc. Soc. Exp. Biol. Med., 203, 6-12 (1995).
125. L. J. Guillette and E. A. Guillette, Environmental contaminants and reproductive abnormalities in wildlife: Implications for public health? Toxicol. Ind. Health, 12, 537-550 (1996).
126. S. F. Arnold, P. M. Vonier, B. M. Collins, D. M. Klotz, L. J. Guillette, and J. A. McLachlan. In vitro synergistic interaction of alligator and human estrogen receptors with combinations of environmental chemicals, Environ. Health Perspect., 105(Suppl. 3), 615-618 (1997).
127. P. M. Vonier, D. A. Crain, J. A. McLachlan, L. J. Guillette, and S. F. Arnold, Interaction of environmental chemicals with the estrogen and progesterone receptors from the oviduct of the American alligator, Environ. Health. Perspect., 104, 1318-1322 (1996).
128. G. W. Bryan, P. E. Gibbs, L. G. Hummerstone, and G. R. Burt. The decline of the gastropod Nucella lapillus around south-west England: Evidence for the effect of tributyltin from antifouling paints, J. Marine Biol. Assoc. UK, 66, 611-640 (1986).
129. J. Toppari, J. C. Larsen, P. Christiansen, A. Giwercman, P. Grandjean, L. J. Guillette, B. Jegou, T. K. Jensen, P. Jouannet, N. Keiding, H. Leffers, J. A. McLachlan, O. Meyer, J. Muller, E. Rajpert De Meyts, T. Scheike, R. Sharpe, J. Sumpter, and N. E. Skakkebaek, Male reproductive health and environmental xenoestrogens, Environ. Health Perspect., 104(Suppl. 4), 741-803 (1996).
130. P. T. Harrison, P. Holmes and C. D. Humfrey, Reproductive health in humans and wildlife: Are adverse trends associated with environmental chemical exposure? Sci. Total Environ., 205, 97-106 (1997).
131. F. Piferrer and E. M. Donaldson, Gonadal differentiation in coho salmon (Oncorhynchus kisutch) after a single treatment with bandrogen or estrogen at different stages during ontogenesis, Aquaculture, 77, 251-262 (1989).
132. B. Fisher, J. P. Costantino, D. L. Wickerham, C. K. Redmond, M. Kavanah, W. M. Cronin, V. Vogel, A. Robidoux, N. Dimitrov, J. Atkins, M. Daly, S. Wieand, E. Tan Chiu, L. Ford, and N. Wolmark, Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study, J. Natl. Cancer Inst., 90, 1371-1388 (1998).
133. V. C. Jordan and S. P. Robinson, Species-specific pharmacology of antiestrogens: Role of metabolism, Fed. Proc., 46, 1870-1874 (1987).
134. G. N. Wogan, Review of the toxicology of tamoxifen, Semin. Oncol, 24, S1-87-S1-97 (1997).
135. S. R. Tannenbaum, Comparative metabolism of tamoxifen and DNA adduct formation and in vitro studies on genotoxicity, Semin. Oncol., 24(Suppl. I), S1-81-S1-86 (1997).
136. J. E. Coe, K. G. Ishak, J. M. Ward, and M. J. Ross, Tamoxifen prevents induction of hepatic neoplasms by zeranol, and estrogenic food contaminant, Proc. Natl Acad. Sci. USA, 89, 1085-1089 (1992).
137. K. V. Ramakrishna, P. W. Fan, C. S. Boyer, D. Dalvie, and J. L. Bolton, Oxo substituents markedly alter the phase II metabolism of alpha-hydroxybutenylbenzenes: Models probing the bioactivation mechanisms of tamoxifen, Chem. Res. Toxicol., 10, 887-894 (1997).
138. D. H. Phillips, P. L. Carmichael, A. Hewer, K. J. Cole, I. R. Hardcastle, G. K. Poon, A. Keogh, and A. J. Strain, Activation of tamoxifen and its metabolite alpha-hydroxytamoxifen to DNA-binding products: Comparisons between human, rat and mouse hepatocytes, Carcinogenesis, 17, 89-94 (1996).
139. L. Dasaradhi and S. Shibutani, Identification of tamoxifen adducts formed by alpha-sulfate tamoxifen and alpha-acetoxytamoxifen, Chem. Res. Toxicol, 10, 189-196 (1997).
140. 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite, Carcinogenesis, 15, 2087-2094 (1994).
141. K. Randerath, J. Bi, N. Mabon, P. Sriram, and B. Moorthy, Strong intensification of mouse hepatic tamoxifen DNA adduct formation by pretreatment with the sulfotransferase inhibitor and ubiquitous environmental pollutant pentachlorophenol, Carcinogenesis, 15, 797-800 (1994).
142. C. Mani, H. V. Gelboin, S. S. Park, R. Pearce, A. Parkinson, and D. Kupfer, Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation, Drug Metab. Disp., 21, 645-656 (1993).
143. C. K. Lim, Z.-X. Yuan, J. H. Lamb, I. N. White, F. De Matteis, and L. L. Smith, A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes, Carcinogenesis, 15, 589-593 (1994).
144. 32P-Postlabelled DNA adducts in liver obtained from women treated with tamoxifen, Carcinogenesis, 16, 1651-1654 (1995).
145. D. N. Pathak, K. Pongraez, and W. J. Bodell, Uterine peroxidase activation of tamoxifen metabolites to form DNA adducts: Comparison with the adducts formed in the uterus of Sprague-Dawley rats treated with tamoxifen, Proc. Am. Assoc. Cancer. Res., 37, 119 (1996).
146. P. L. Carmichael, A. H. N. Ugwumadu, P. Neven, et al., Lack of genotoxicity of tamoxifen in human endometrium, Cancer Res., 56, 1475-1479 (1996).
147. D. C. Eberhard, Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin, Mol. Pharmacol., 40, 859-867 (1991).
148. G. A. Hazelton and C. D. Klaassen, UDP-glucuronosyltransferase activity toward digitoxigenin-monodigitoxide. Differences in activation and induction properties in rat and mouse liver, Drug Metab. Disp., 16, 30-36 (1988).
149. W. J. Scott, R. P. Beliles, and H. I. Silverman, The comparative acute toxicity of two cardiac glycosides in adult and newborn rats, Toxicol. Appl. Pharmacol., 20, 599-601 (1971).
150. R. S. Gupta, A. Chopra, and D. K. Stetsko, Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis), J. Cell Physiol., 127, 197-206 (1986).
151. W. B. Gill, G. F. Schumacher, M. Bibbo, F. H. Straus, and H. W. Schoenberg, Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities, J. Urol., 122, 36-39 (1979).
152. D. A. Barsotti, L. J. Abrahamson, and J. R. Allen. Hormonal alterations in female rhesus monkeys fed a diet containing 2,3,7,8-tetrachlorodibenzo-p-dioxin, Bull. Environ. Contamin. Toxicol., 21, 463-469 (1979).
153. S. E. Rier, D. C. Martin, R. E. Bowman, W. P. Dmowski, and J. L. Becker, Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin, Fundam. Appl. Toxicol., 27, 433-441 (1993).
154. R. L. Cooper and R. J. Kavlock, Endocrine disruptors and reproductive development: A weight-of-evidence overview, J. Endocrinol., 152, 159-166 (1997).
155. T. A. Mably, R. W. Moore, and R. E. Peterson, In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Effects on androgenic status, Toxicol. Appl. Pharmacol., 114, 97-107 (1992).
156. T. A. Mably, D. L. Bjerke, R. W. Moore, A. Gendron-Fitzpatrick, and R. E. Peterson, In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 3. Effects on spermatogenesis and reproductive capability, Toxicol. Appl. Pharmacol., 114, 118-126 (1992).
157. L. E. Gray and J. S. Ostby, In utero 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters reproductive morphology and function in female rat offspring, Toxicol. Appl. Pharmacol., 133, 285-294 (1995).
158. R. F. Shore, and P. E. Douben, Predicting ecotoxicological impacts of environmental contaminants on terrestrial small mammals, Rev. Environ. Contamin. Toxicol., 134, 49-89 (1994).
159. T. Babic-Gojmerac, Z. Kniewald, and J. Kniewald. Testosterone metabolism in neuroendocrine organs in male rats under atrazine and deethylatrazine influence, J. Steroid. Biochem. 33, 141-146 (1989).
160. S. Jobling, T. Reynolds, R. White, M. G. Parker, and J. P. Sumpter, A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic, Environ. Health Perspect., 103, 582-587 (1995).
161. L. E. J. Gray, J. M. Ostby, and R. Marshall, The fungizide vinclozolin inhibits morphological sex differentiation in the male rat, Biol. Reprod., 48(Suppl.), 97 (1993).
162. W. R. Kelce, E. Monosson, M. P. Gamcsik, S. C. Laws, and L. E. Gray, Environmental hormone disruptors: Evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites, Toxicol. Appl. Pharmacol., 126, 276-285 (1994).
163. W. R. Kelce, C. R. Stone, S. C. Laws, L. E. Gray, J. A. Kemppainen, and E. M. Wilson, Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist, Nature, 375, 581-585 (1995).
164. M. J. DeVito, T. Thomas, E. Martin, T. H. Umbreit, and M. A. Gallo, Antiestrogenic action of 2,3,7,8-tetrachlorodibenzo-p-dioxin: Tissue-specific regulation of estrogen receptor in CDI mice, Toxicol. Appl. Pharmacol., 113, 284-292 (1992).
165. C. F. Facemire, T. S. Gross, and L. J. Guillette, Reproductive impairment in the Florida panther: Nature or nurture? Environ. Health Perspect., 103(Suppl. 4), 79-86 (1995).
166. S. DeGuise, D. Martineau, P. Beland, and M. Fournier, Possible mechanisms of action of environmental contaminants on St. Lawrence beluga whales (Delphinapterus leucas), Environ. Health Perspect., 103(Suppl. 4), 73-77 (1995).
167. D. M. Fry, and C. K. Toone, DDT-induced feminization of gull embryos, Science, 21(213), 922-924 (1981).
168. M. K. Walker, P. M. Cooke, B. C. Butterworth, E. W. Zabel, and R. E. Peterson, Potency of a complex mixture of polychlorinated diazo-p-dioxin, dibenzofuran, and biphenyl congeners compared to 2,3,7,8-tetrachlorodibenzo-p-dioxin in causing fish early life stage mortality, Fundam. Appl. Toxicol., 30(2), 178-186 (1996).
169. A. Sukumar and P. R. Karpagaganapathy, Pesticide-induced atresia in ovary of a fresh water fish, Colisa lalia (Hamilton-Buchanan), Bull Environ. Contamin. Toxicol., 48, 457-462 (1992).
170. C. P. Wild, R. Hasegawa, L. Barraud, S. Chutimataewin, B. Chapot, I. Nobuyuki, and R. Montesano, Aflatoxin-albumin adducts: A basis for comparative carcinogenesis between animals and humans, Cancer Epidemiol. Biomarkers Prev., 5, 179-189 (1996).